EcoDrugPlus

Somatostatin Receptor 4

Ensembl ID : ENSDORG00000010486
Gene Symbol: SSTR4
4 Cross references
102 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSDORG00000010598
Gene Symbol: SPHK2
3 Cross references
209 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSDORG00000001655
Gene Symbol: S1PR1
4 Cross references
194 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSDORG00000000499
Gene Symbol: SYK
3 Cross references
203 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSDORG00000006774
Gene Symbol: LOC105986673
4 Cross references
211 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSDORG00000011035
Gene Symbol: SRD5A2
4 Cross references
266 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSDORG00000004639
Gene Symbol: SOAT1
4 Cross references
211 Possible Orthologues:

Stromelysin-1-Like

Ensembl ID : ENSDORG00000015114
Gene Symbol: LOC105980671
3 Cross references
501 Possible Orthologues:

Sucrase-Isomaltase

Ensembl ID : ENSDORG00000005876
Gene Symbol: SI
3 Cross references
201 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSDORG00000009317
Gene Symbol: SNCA
4 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSDORG00000006212
Gene Symbol: TACR1
3 Cross references
271 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSDORG00000015619
Gene Symbol: TACR2
3 Cross references
200 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).